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LETTER TO THE EDITOR
EDITOR Activation ofliver cirrhosis (hepatocellu-
lar insufficiency, increase of ascites and gastroesoph-
ageal varices, worsening of encephalopathy) is very
difficult to cure. Conservative management is often
ineffective, and many patients die during the episode
of activation. We report our experience with control
of this syndrome by lymphosorbtion.
Combined treatment, lymphosorbtion plus medi-
cal therapy, was accomplished in 28 patients with
Child-Pugh’s Class C liver cirrhosis (Group 1). Lymph
purification and reinfusion (500 ml to 1500 ml daily)
was performed using chronic external surgical cathe-
terization of the thoracic duct. The carbon adsorbent
with fibers of8x 10-3mm to 12x 10-3mm diameter and
2m-/g external geometric surface was used for lymph
purification. Control prospective Group 2 of 30
patients with C Class cirrhosis received only medical
therapy.
Control ofactivation was achieved in 25 (89%) vs 17
(56%) patients,respectively. Hospital mortality rates
were4% and 17% in Groups and 2. In two weeks after
beginning of the treatment,decrease of ascites was seen
in 100% and 70% of patients, respectively. Gastroeso-
phageal varices decreased in diameter in 50% vs 0%,
and encephalopathy regressed in 90% vs 30% of pa-
tients. The duration ofhospital stay was shorter by two
times in Group than in Group 2.
These data show that lymphosorbtion combined
with medical therapy is more effective than medical
therapy alone in the management of patients with liver
cirrhosis complicated by activation.
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